Simultaneous Liver Kidney (SLK) Allocation Policy Kidney Transplantation Committee Fall 2015 1.

Slides:



Advertisements
Similar presentations
Ken Andreoni, MD Chair UNOS Kidney Comm The Ohio State University
Advertisements

Kidney Transplantation Committee Update John J. Friedewald, MD Committee Chair Meetings.
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
Ad Hoc Disease Transmission Advisory Committee Spring 2015.
The Deceased Donor Kidney Allocation System
Proposal to Substantially Revise the National Kidney Allocation System
Guidance to Organ Procurement Organizations for Allocation of Heart-Lung Blocks (Resolution 12) OPTN/UNOS Thoracic Organ Transplantation Committee Dr.
Kidney Transplantation Committee Spring  Implemented Dec. 4, 2014  6 month data will be shared at Aug-Oct regional meetings  Monitoring community.
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
Proposal to Require the Collection of Serum Lipase for all Pancreas Donors (Resolution 5) Pancreas Transplantation Committee Jonathan Fridell, MD, Chair.
The New Kidney Allocation System Gautham Mogilishetty, MD Associate Professor of Medicine Division of Nephrology and Transplantation University of Cincinnati.
Greater Consistency in Candidate and Deceased Donor HLA Typing Requirements Across Organ Types Histocompatibility Committee Spring 2014.
Addressing the Requirements Outlined in the HIV Organ Policy Equity Act Organ Procurement Organization Committee Spring 2015.
Liver and Intestinal Organ Transplantation Committee Report to the Board of Directors June 25-26, 2012 Richmond, VA Kim M. Olthoff, MD, Chair David C.
OPTN Liver and Intestinal Organ Transplantation Committee Update Spring 2012 Kim Olthoff, MD, Chair David Mulligan, MD, Vice-chair.
Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair.
OPTN Proposal to Revise the Lung Allocation Score (LAS) System and Salient Activities of the Thoracic Organ Transplantation Committee.
1 Revising Kidney Paired Donation Pilot Program Priority Points Kidney Transplantation Committee Fall 2015.
1 Proposal to Revise Facilitated Pancreas Allocation Policy Pancreas Transplantation Committee Fall 2015.
1 OPTN Update Brian Shepard Chief Executive Officer UNOS November 17, 2015.
OPTN Minority Affairs Committee Update March 13, 2012 Meeting Chicago O’Hare Hilton.
1 Proposal to Modify Pediatric Lung Allocation Policy Thoracic Organ Transplantation Committee Fall 2015.
Clarify Policy Language and Process for Individual Waiting Time Transfer Patient Affairs Committee Spring 2015.
1 Kidney Transplantation Committee Spring Recent Public Comment Proposals  OPTN Kidney Paired Donation (KPD) Priority Points  Changes apply.
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
1 Simultaneous Liver-Kidney (SLK) Allocation Kidney Transplantation Committee Spring 2016.
Membership & Professional Standards Committee (MPSC)
Enhancing Liver Distribution
Pediatric Transplantation Committee
National Liver Review Board (NLRB)
Pediatric Transplantation Committee
Pancreas Transplantation Committee
Improving Allocation of En Bloc Kidneys Public Comment Proposal
Pancreas Transplantation Committee
Expedited Organ Placement Concept Paper
Thoracic Organ Transplantation Committee
OPTN/UNOS Kidney Transplantation Committee
OPTN/UNOS Kidney Transplantation Committee
Pediatric Transplantation Committee
Ad Hoc Geography Committee Update
Changes to HCC Criteria for Auto Approval
OPTN/UNOS Thoracic Organ Transplantation Committee
Pancreas Program Functional Inactivity
Thoracic Organ Transplantation Committee Spring 2019
Modify HOPE Act Variance to Include Other Organs
Liver and Intestinal Organ Transplantation Committee
Ethical Implications of Multi-Organ Transplants (MOT)
Pediatric Transplantation Committee
Kidney Transplantation Committee
Kidney Transplantation Committee
Living Donor Committee Spring 2014
Liver and Intestine Committee
Pediatric Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Proposal to Delay the HCC Exception Score Assignment
Proposal to Notify Patients Having an Extended Inactive Status
Living Donor Committee Spring 2014
Liver and Intestinal Organ Transplantation Committee
Thoracic Organ Transplantation Committee
Living Donor Committee
Proposal for the Definition of Pancreas Graft Failure
MELD Exception Scores During NLRB Transition
Pediatric Transplantation Committee Fall 2014
Pediatric Transplantation Committee
Histocompatibility Committee
Pancreas Transplantation Committee
MPSC Transplant Program Performance Measures (Outcome Measures)
Histocompatibility Committee
Presentation transcript:

Simultaneous Liver Kidney (SLK) Allocation Policy Kidney Transplantation Committee Fall

SLK allocation not based on standard medical criteria for kidney function; only based on geographic proximity of donor and candidate Current policy does not provide clear rules for SLK allocation beyond local level Inconsistent allocation practices across the country mean candidates are not being treated equitably What problems will the proposal solve?

Number of SLK transplants by year Analyses are based on deceased donor SLK transplants performed during SLK transplants with other organs were excluded from the tabulation.

Establish medical eligibility criteria for SLK Ensure a balance of fairness and utility in allocation of kidneys Kidney community Resolve inconsistency between multi-organ and DD liver allocation policy re: regional SLK allocation Ensure safety net for liver recipients who don’t meet SLK medical eligibility criteria but need a kidney tx soon after liver tx Liver community Provide clearer liver- kidney allocation policies Provide information in UNOS computer system to indicate to OPOs when SLK allocation is permissible OPO community What are the goals of this proposal? Main goal: Establish SLK allocation policy that addresses different perspectives within the transplant community

— Societies hold consensus conference on the issue 2009— Kidney and Liver Committees sponsor public comment proposal 2010—Committees decide not to move forward due to complex IT programming (mostly due to kidney allocation variances) and development of new KAS 2013—KAS is approved by Board, SLK working group is formed 2014—KAS is implemented, removing all variances Did the Committee review prior work and history?

2 main policy elements Medical eligibility criteria for local/regional SLK allocation “Safety Net” Prioritization on the kidney alone waiting list for liver recipients with post-operative dialysis dependency or significant renal dysfunction How does the proposal address the problem statement?

SLK Medical Eligibility Criteria 7

Transplant nephrologist must confirm candidate has one of the following: And tx hospital must document one of the following in the medical record: 1. Chronic kidney disease with measured or calculated GFR less than or equal to 60 mL/min for greater than 90 days Dialysis for ESRD Most recent eGFR/CrCl is at or below 35 mL/min at the time of registration on kidney waiting list 2. Sustained acute kidney injuryDialysis for six consecutive weeks eGFR/CrCl at or below 25 mL/min for at least six consecutive weeks Any combination of #1 and #2 above for six consecutive weeks 3. Metabolic diseaseDiagnosis of: Hyperoxaluria Atypical HUS from mutations in factor H and possibly factor I Familial non-neuropathic systemic amyloid Methylmalonic aciduria Updated Recommendations KDOQI criteria

Transplant nephrologist must confirm candidate has one of the following: And tx hospital must document one of the following in the medical record: 1. Chronic kidney disease with a measured or calculated GFR less than or equal to 60 mL/min for greater than 90 days Dialysis for ESRD Most recent eGFR/CrCl is at or below 35 mL/min at the time of registration on kidney waiting list 2. Sustained acute kidney injuryDialysis for six consecutive weeks eGFR/CrCl at or below 25 mL/min for at least six consecutive weeks (reported every 7 days) Any combination of #1 and #2 above for six consecutive weeks 3. Metabolic diseaseDiagnosis of: Hyperoxaluria Atypical HUS from mutations in factor H and possibly factor I Familial non-neuropathic systemic amyloid Methylmalonic aciduria How will this be operationalized? Programmed into UNet ℠

Transplant nephrologist must confirm candidate has one of the following: And tx hospital must document one of the following in the medical record: 1. Chronic kidney disease with a measured or calculated GFR less than or equal to 60 mL/min for greater than 90 days Dialysis for ESRD Most recent eGFR/CrCl is at or below 35 mL/min at the time of registration on kidney waiting list 2. Sustained acute kidney injuryDialysis for six consecutive weeks eGFR/CrCl at or below 25 mL/min for at least six consecutive weeks (reported every 7 days) Any combination of #1 and #2 above for six consecutive weeks 3. Metabolic diseaseDiagnosis of: Hyperoxaluria Atypical HUS from mutations in factor H and possibly factor I Familial non-neuropathic systemic amyloid Methylmalonic aciduria How will this be monitored? UNOS staff will request documentation in medical record

 Proposal does NOT create SLK listing criteria  Liver candidates can still be registered on kidney waiting list whether they meet proposed medical criteria  Current OPTN policy does NOT require any kidney candidate (kidney alone or kidney + other organs) to meet medical requirements in order to be registered on the kidney waiting list  Transplant programs have complete discretion as to which patients to register on the kidney waiting list  Once registered, kidney candidates are prioritized through match classification or points priority based on medical criteria  SLK medical eligibility criteria will add to the different types of priority applied for different types of kidney candidates Important Distinction: Eligibility v. Listing Criteria 11

Does liver candidate meet SLK eligibility criteria? No Candidate is not eligible to receive kidney with liver offer Yes Candidate is eligible for local SLK allocation Is candidate also eligible for Liver Share 35 priority? No Candidate is eligible for local SLK allocation only Yes Candidate is eligible for regional SLK allocation Proposed SLK Allocation 12

Due to recent feedback from Liver Committee, the following policy clarifications are actively under construction: Clarifying that local SLK candidates must only meet medical eligibility criteria in order to be eligible Amending proposal so that it will not apply to pediatric SLK candidates Specifying that OPO must extend SLK offers to eligible Share 35 candidates in the host OPO’s region if offering to liver/kidney candidates Specific feedback needed on one element: Under what circumstances should national SLK candidates receive priority? Anticipated Post-Public Comment Changes—SLK Allocation 13

Recipient survival Cohort: recipients Mar 31, 2002 – Dec 21, 2012 p-value= LI AloneSLK White70%62% Diabetes27%41% MELD*3627 KDPI%5040 Age*5556 LI CIT* LI AloneSLK White73%65% Diabetes23%38% MELD*1728 KDPI%5040 Age*5557 LI CIT* * Medians are shown Crude survival advantage of receiving a kidney vs. liver alone

 If OPO recovers a kidney with liver, heart, lung, or pancreas, must allocate kidney locally as part of local multi-organ combination  OPO has discretion to choose between following combinations:  Local heart/kidney candidate  Local liver/kidney candidate  Local lung/kidney candidate  Pancreas/kidney candidates (local through regional/national zero mismatch offers) How Multi-Organ Involving KI works 15

 If OPO recovers a kidney with liver, heart, lung, or pancreas, must allocate kidney locally as part of local multi-organ combination  OPO has discretion to choose between following combinations:  Local heart/kidney candidate  Local liver/kidney candidate (eligible local/regional offers)  Local lung/kidney candidate  Pancreas/kidney candidates (local through regional/national zero mismatch offers) How Multi-Organ Involving KI Will Work if Approved 16

SLK ‘Safety Net’ Policy 17

Kidney patient survival: with vs. without prior liver tx Waiting list survival Recipient survival Time period: Mar 31, 2002 – Dec 31, 2012 With LI (<=1) With LI (>1) W/t LI White75%74%45% Age (median) With LI (<=3) With LI (>3) W/t LI White70%78%45% Age (median)576054

Liver recipients receive additional local match classification priority on the kidney waiting list if, on a date that is days after the most recent LI tx, patient is on kidney waiting list and is either: on dialysis for ESRD or eGFR is at or below 20 mL/min Once candidate is eligible, safety net priority will apply until candidate receives a kidney transplant under this listing or is removed from waiting list for other reason Recommended ‘Safety Net’ Policy

No medical criteria to meet before liver transplant for safety net priority to apply— this element focuses on the 2-12 month period after liver transplant SLK recipients not eligible for ‘safety net’ priority unless kidney graft failure occurs within 90 days of the SLK transplant All other liver recipients (including recipients of liver transplant with other organs) eligible for safety net priority if criteria is met Other Important ‘Safety Net’ Details 21

Programs will report in UNet ℠ candidate eligibility factors for safety net priority Functionality similar to reporting criteria for waiting time points Safety net priority applies only if criteria is met between 2-12 months of liver transplant Programs must document in medical record that criteria was met in this timeframe How will this be operationalized/monitored? 22

OPTN Strategic Plan Goal: Increase equity in access to transplants Objective: Establish clearer rules for allocation of multiple organs to a single candidate, especially liver-kidney candidates How does this proposal support the OPTN Strategic Plan? 23

Mark Aeder, MD Committee Chair Regional representative name (RA will complete) Region X Representative address Gena Boyle Project Liaison Questions? 24

Extra SLK slides 25

Ethics, OPO, Liver, Minority Affairs, & Ops and Safety committeesOPTN RegionsASTASTSNKFAUA Who did the Committee collaborate with? 26

Transplant nephrologist must confirm candidate has one of the following: And tx hospital must document one of the following in the medical record: 1. Chronic kidney disease1.Dialysis for ESRD 2.eGFR at or below 35 mL/min 2. Sustained acute kidney failure1.Dialysis for six consecutive weeks 2.eGFR/CrCl at or below 25 mL/min for at least six consecutive weeks (documented every 7 days) 3.Any combination of #1 and #2 above for six consecutive weeks 3. Metabolic diseaseDiagnosis of: 1.Hyperoxaluria 2.Atypical HUS from mutations in factor H and possibly factor I 3.Familial non-neuropathic systemic amyloid 4.Methylmalonic aciduria Medical Eligibility Criteria (as presented for community feedback)

Kidney graft survival Cohort: recipients Mar 31, 2002 – Dec 31, 2012 Recipient survival SLK (ren. failure)SLK (no ren. failure)KI White62%65%45% Age (median)565754

Medical criteria for CKD needs to be spelled out Specify a duration for GFR Require more than one GFR measurement over a period of time for CKD Require specific GFR measurement to ensure consistency Regional Feedback (SLK medical eligibility criteria) 29

AST Generally supportive Concerned CKD definition does not contain time component; suggested adopting NKF KDOQI criteria (90 days) Requested requiring a consistent method of measuring GFR NKF Supports updated criteria, especially having nephrologist confirm candidate diagnosis Remain concerned with category #2 being labeled as ‘kidney failure’, would suggest it be re-labeled AUA Generally rejected notion that SLK recipients have better outcomes if receiving both organs from the same donor and would encourage use of living donors in this setting instead of SLK Constituency Group Feedback (SLK medical eligibility criteria) 30

Several regions supported proposal because of inclusion of safety net Concerns it may be disincentive for liver recipient to find a living KI donor Suggestion to distinguish between medical need for the kidney pre and post liver Tx Suggestion priority should not apply for Sequence B, only for C & D (KDPI greater than 35%) Suggestion to expand priority beyond the local level Regional Feedback (Safety Net)

NKF Strongly support Appreciative of the changes made since 2009 proposal AUA No comments on ‘safety net’ priority AST Support ‘safety net’ prioritization Requested Committee consider no priority for sequence B (KDPI 21-34%) because it could be disincentive for candidate to seek a living donor Constituency Group Feedback (Safety Net) 32

The Impact of the Problem by #s 500—the approximate number of SLK transplants per year 50-65—the number of SLK recipients with no pre-tx dialysis —the number of recipients with <2 months of dialysis 48%--the percentage of kidneys used in SLK transplants that had KDPI < 35% (usually prioritized for peds)

34 Kidney transplants after liver transplants (2005-6/2013) by kidney donor type Analyses are based on first deceased and living donor kidney alone transplants that occurred during /2013 and followed a liver alone transplant that was still functioning at the time of the subsequent kidney transplant.

April 2015: Kidney Committee votes on SLK policy for public comment May 2015: Representatives from the Thoracic Committee join SLK group to discuss applicability to thoracic/kidney combinations June 2015: Focus of this working group expands to larger order of allocation issues; Ethics Committee weighs in with prior work August-October 2015: SLK and adult heart allocation proposals released for public comment January-March 2016: Possible public comment proposals: incorporate thoracic/kidney medical criteria; heart/lung allocation policy/order of allocation for multi-organ 2016: one policy proposal is submitted to the Board of Directors that addresses all issues in a comprehensive way Multi-Organ Project Timeline

Classification Candidates that are within the: And are: 1OPO’s DSA Zero antigen mismatch, CPRA greater than or equal to 80%, and either pancreas or kidney-pancreas candidates 2OPO’s DSA CPRA greater than or equal to 80% and either pancreas or kidney-pancreas candidates 3OPO’s region Zero antigen mismatch, CPRA greater than or equal to 80%, and are either pancreas or kidney-pancreas candidates 4Nation Zero antigen mismatch, CPRA greater than or equal to 80%, and either pancreas or kidney-pancreas candidates 5OPO’s DSA Pancreas or kidney-pancreas candidates Kidney-Pancreas Allocation